PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr

Author： Xie Chun   Patel Rahul   Wu Tianfu   Zhu Jiankun   Henry Tamika   Bhaskarabhatla Madhavi   Samudrala Renuka   Tus Katalin   Gong Yimei   Zhou Hui   Wakeland Edward K.   Zhou Xin J.   Mohan Chandra  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.19, Iss.4, 2007-04, pp. : 509-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma

By  

Current Molecular Medicine, Vol. 15, Iss. 1, 2015-01 ,pp. : 82-93

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT signaling and systemic autoimmunity

By Patel Rahul   Mohan Chandra  

Immunologic Research, Vol. 31, Iss. 1, 2005-02 ,pp. : 47-55

Humana Press, Inc

Access to resources Recommend Favorite

PI 3-kinase, mTOR, protein synthesis and cancer

By Vogt P.K.  

Trends in Molecular Medicine, Vol. 7, Iss. 11, 2001-11 ,pp. : 482-484

Elsevier

Access to resources Recommend Favorite

Resistin-Like Molecule-α Causes Lung Injury in Rats with Acute Pancreatitis by Activating the PI-3K/Akt-NF-κB Pathway and Promoting Inflammatory Cytokine Release

By  

Current Molecular Medicine, Vol. 16, Iss. 7, 2016-09 ,pp. : 677-687

Bentham Science Publishers

Access to resources Recommend Favorite

PI-3k-Akt axis inhibits apoptosis in normal human megakaryoblasts and is efficiently activated by thrombopoietin

By Majka M.   Ratajczak J.   Gewirtz A.M.   Ratajczak M.Z.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1492-1492

Elsevier

Access to resources Recommend Favorite